| Literature DB >> 29222328 |
Yue Hu1, Ivana Semova1, Xiaowei Sun1, Hong Kang1, Satyapal Chahar1, Anthony N Hollenberg2, David Masson3, Matthew D Hirschey4, Ji Miao5, Sudha B Biddinger6.
Abstract
Although calorically equivalent to glucose, fructose appears to be more lipogenic, promoting dyslipidemia, fatty liver disease, cardiovascular disease, and diabetes. To better understand how fructose induces lipogenesis, we compared the effects of fructose and glucose on mammalian target of rapamycin complex 1 (mTORC1), which appeared to have both positive and negative effects on lipogenic gene expression. We found that fructose acutely and transiently suppressed mTORC1 signaling in vitro and in vivo The constitutive activation of mTORC1 reduced hepatic lipogenic gene expression and produced hypotriglyceridemia after 1 week of fructose feeding. In contrast, glucose did not suppress mTORC1, and the constitutive activation of mTORC1 failed to suppress plasma triglycerides after 1 week of glucose feeding. Thus, these data reveal fundamental differences in the signaling pathways used by fructose and glucose to regulate lipid metabolism.Entities:
Keywords: dyslipidemia; fructose; glucose; lipogenesis; mammalian target of rapamycin (mTOR); metabolic syndrome
Mesh:
Substances:
Year: 2017 PMID: 29222328 PMCID: PMC5808762 DOI: 10.1074/jbc.M117.782557
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157